Oncovista Innovative Therapies ROA 2024

Oncovista Innovative Therapies Aktienanalyse

What does Oncovista Innovative Therapies do?

Oncovista Innovative Therapies Inc. is an emerging biotechnology company from the USA that specializes in the development of innovative cancer therapies. Founded in 2007, the company is headquartered in Chicago, Illinois. Oncovista Innovative Therapies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Oncovista Innovative Therapies's Return on Assets (ROA)

Oncovista Innovative Therapies's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Oncovista Innovative Therapies's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Oncovista Innovative Therapies's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Oncovista Innovative Therapies’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Oncovista Innovative Therapies stock

What is the Return on Assets (ROA) of Oncovista Innovative Therapies this year?

The Return on Assets (ROA) of Oncovista Innovative Therapies is 0 undefined this year.

What was the ROA of Oncovista Innovative Therapies compared to the previous year?

The ROA of Oncovista Innovative Therapies has increased by 0% compared to the previous year.

What consequences do high ROA have for investors of Oncovista Innovative Therapies?

A high ROA is advantageous for investors of Oncovista Innovative Therapies, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Oncovista Innovative Therapies?

A low ROA can be unfavorable for investors of Oncovista Innovative Therapies as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Oncovista Innovative Therapies affect the company?

An increase in ROA of Oncovista Innovative Therapies can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Oncovista Innovative Therapies impact the company?

A reduction in the ROA of Oncovista Innovative Therapies can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Oncovista Innovative Therapies?

Some factors that can influence the ROA of Oncovista Innovative Therapies include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Oncovista Innovative Therapies important for investors?

The ROA of Oncovista Innovative Therapies is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Oncovista Innovative Therapies take to improve ROA?

To improve ROA, Oncovista Innovative Therapies can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Oncovista Innovative Therapies pay?

Over the past 12 months, Oncovista Innovative Therapies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oncovista Innovative Therapies is expected to pay a dividend of 0 USD.

What is the dividend yield of Oncovista Innovative Therapies?

The current dividend yield of Oncovista Innovative Therapies is .

When does Oncovista Innovative Therapies pay dividends?

Oncovista Innovative Therapies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Oncovista Innovative Therapies?

Oncovista Innovative Therapies paid dividends every year for the past 0 years.

What is the dividend of Oncovista Innovative Therapies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Oncovista Innovative Therapies located?

Oncovista Innovative Therapies is assigned to the 'Health' sector.

Wann musste ich die Aktien von Oncovista Innovative Therapies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Oncovista Innovative Therapies from 9/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did Oncovista Innovative Therapies pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of Oncovista Innovative Therapies in the year 2023?

In the year 2023, Oncovista Innovative Therapies distributed 0 USD as dividends.

In which currency does Oncovista Innovative Therapies pay out the dividend?

The dividends of Oncovista Innovative Therapies are distributed in USD.